OHVIRA is a rare variety of congenital anomaly of mullerian duct. The syndrome includes uterus didelphys, obstructed hemivagina and ipsilateral renal anomaly, also known as Herlyn-Werner-Wunderlich (HWW) syndrome. A 15yrs old girl was referred to our department with regular menstrual period and cyclic pain in lower abdomen of 5-6 months duration. USG and MRI established the final diagnosis of OHVIRA syndrome. Drainage of hematocolpos of obstructed hemivagina and excision of septum was done and patient was discharged under satisfactory condition to come for follow-up. Patient had her normal menses on 28/8/2015. A repeat USG was done which showed didelphus uterus with no collection in endometrial cavity.
Authors report the case of a 55-year-old patient who presented with postmenopausal bleeding. On clinical evaluation uterus was 12 weeks size with a left sided adnexal cystic mass of 8 × 6 cm size. Further imaging studies revealed uterus size of 11.5 × 6.7 × 6.3 cm, left ovarian mass of size 8.4 × 6.7 × 6 cm and endometrial thickness of 17 mm on ultrasonography. She underwent endometrial biopsy to exclude endometrial cancer. The report of which came to be endometrial hyperplasia without atypia. Further MRI study confirmed the findings of USG of a complex cystic lesion of left adnexa 75 × 57 × 60 mm. Tumor marker for ovarian tumors were sent and inhibin B was found to be markedly raised. A provisional diagnosis of GCT (Granulosa cell tumour) was made and staging laparotomy was done. The uterus was found to be 12 × 8 cm size and a left sided ovarian cyst of 8-9 cm size with smooth wall and intact capsule was found. Patient had an uneventful postoperative recovery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.